» Articles » PMID: 35830749

The Practice and Embodiment of "goofballs": A Qualitative Study Exploring the Co-injection of Methamphetamines and Opioids

Overview
Publisher Elsevier
Date 2022 Jul 13
PMID 35830749
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polysubstance use is common among people who use drugs, including the co-use of stimulants and opioids. Research suggests the practice of simultaneous co-injection of methamphetamines and opioids, often referred to as "goofballs", is increasing. As a relatively unique drug use practice, little qualitative research currently exists on goofball injecting. This study explores the practice and embodied experiences of goofball injecting.

Methods: This article draws on in-depth interviews conducted across two qualitative studies undertaken in Vancouver, Canada's Downtown Eastside neighbourhood examining changing dynamics in relation to stimulant use and experiences with an overdose prevention site-based safer supply intervention, respectively. Interviews containing discussions of goofball use (n=29) were extracted from each study and merged into a single qualitative dataset. Data were analysed thematically and focused on the practices and embodied experiences of goofball injection.

Results: Our analysis uncovered how goofball injection represented a complex drug use practice driven by the desire to achieve particular embodied experiences not attainable by using either drug individually. We identified three distinct practices of goofball use: 1) to alter or enhance the effects of opioids; 2) to alter or enhance the effects of methamphetamines; and 3) to balance out the effects of both drugs.

Conclusion: Our study fills an important gap in the polysubstance use literature specifically exploring the co-injection of methamphetamines and opioids. Our findings highlight the need to implement and expand interventions and services attentive to polysubstance use and the role of pleasure in drug taking practices, including expanding non-medicalized opioid and stimulant safer supply initiatives across North America.

Citing Articles

Fentanyl, Heroin, Methamphetamine, and Cocaine Analyte Concentrations in Urine Drug Testing Specimens.

Huhn A, Whitley P, Bolin B, Dunn K JAMA Netw Open. 2024; 7(10):e2441063.

PMID: 39446323 PMC: 11577146. DOI: 10.1001/jamanetworkopen.2024.41063.


U.S. trends in methamphetamine-involved psychiatric hospitalizations in the United States, 2015-2019.

Calcaterra S, Yamkovoy K, Swathi P, Ciccarone D, Del Pozo B, Englander H Drug Alcohol Depend. 2024; 262:111409.

PMID: 39089187 PMC: 11343609. DOI: 10.1016/j.drugalcdep.2024.111409.


A qualitative study on perceptions and experiences of overdose among people who smoke drugs in Vancouver, British Columbia.

Ivsins A, Bonn M, McNeil R, Boyd J, Kerr T Drug Alcohol Depend. 2024; 258:111275.

PMID: 38581922 PMC: 11088499. DOI: 10.1016/j.drugalcdep.2024.111275.


The influence of transformations in supply on methamphetamine initiation among people injecting opioids in the United States.

Mars S, Ondocsin J, Holm N, Ciccarone D Harm Reduct J. 2024; 21(1):57.

PMID: 38443903 PMC: 10913463. DOI: 10.1186/s12954-024-00976-1.


Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada.

Fleming T, Ivsins A, Barker A, Mansoor M, Mayer S, Vakharia S Int J Drug Policy. 2024; 125:104336.

PMID: 38281384 PMC: 11045237. DOI: 10.1016/j.drugpo.2024.104336.


References
1.
Bluthenthal R, Wenger L, Chu D, Lorvick J, Quinn B, Thing J . Factors associated with being asked to initiate someone into injection drug use. Drug Alcohol Depend. 2015; 149:252-8. PMC: 5048683. DOI: 10.1016/j.drugalcdep.2015.02.011. View

2.
Nolan M, Shamasunder S, Colon-Berezin C, Kunins H, Paone D . Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention. J Urban Health. 2019; 96(1):49-54. PMC: 6391300. DOI: 10.1007/s11524-018-00343-z. View

3.
Duff C . The pleasure in context. Int J Drug Policy. 2007; 19(5):384-92. DOI: 10.1016/j.drugpo.2007.07.003. View

4.
Palmer A, Scott N, Dietze P, Higgs P . Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduct J. 2020; 17(1):14. PMC: 7047412. DOI: 10.1186/s12954-020-00360-9. View

5.
McKetin R, McLaren J, Lubman D, Hides L . The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006; 101(10):1473-8. DOI: 10.1111/j.1360-0443.2006.01496.x. View